SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Cohen who wrote (126)12/2/1997 12:03:00 AM
From: alexander orlov  Respond to of 942
 
although the cost of liver function monitoring may initialy appear prohibitive, keep in mind that diabetes is a chronic condition often
requiring lifetime treatment..the new labeling may affect the sales slightly initialy ... long term this is not a big deal will we see a bounce in am i hope so.... ao



To: Richard Cohen who wrote (126)12/2/1997 12:18:00 AM
From: DAY TRADER  Respond to of 942
 
I THINK THE PRICE SETBACK WAS OVERDONE AND IS AT MOST TEMPORARY

STOCK SHOULD REBOUND NICELY IN THE NEAR TERM.

DT


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News